This book delves into the forefront of cancer treatment, exploring the revolutionary potential of nanoparticle-based drug delivery systems. Authored by leading experts, it provides a comprehensive examination of the latest advancements in nanotechnology and their role in transforming cancer therapy. Covering a broad spectrum of topics—including targeted drug delivery, advanced imaging techniques, and personalized medicine—it presents cutting-edge research and innovations that enhance therapeutic precision, reduce side effects, and improve clinical outcomes. With a focus on transformative technologies, this book is an essential resource for researchers, clinicians, and healthcare professionals aiming to understand and harness the power of nanotechnology in reshaping cancer care, paving the way for more effective and personalized treatment approaches.
“A Wicked Snow” has been added to your cart. View cart
SKU
EBP-1924206
Categories Condensed Matter, General, Medical, Nanoscience, Oncology, Physics, Science, Technology & Engineering
Tags Gautam Patel, Nirav J. Joshi
Nanoparticle Delivery in Cancer Care
$169.00 Original price was: $169.00.$126.75Current price is: $126.75.
Purchase & earn 1,268 points!
| Book Author | Gautam Patel, Nirav J. Joshi |
|---|---|
| ISBN | 9789819504565 |
| Language | English |
| Publisher | Springer |
| Publication Date | 08-19-2025 |
| Format | eBook |
Only logged in customers who have purchased this product may leave a review.
Related products
-
The Whittiers
Rated 4.20 out of 5$9.99Original price was: $9.99.$7.49Current price is: $7.49. Purchase & earn 75 points!Add to cart -
The Everything Build Your Vocabulary Book
$9.95Original price was: $9.95.$7.46Current price is: $7.46. Purchase & earn 75 points!Add to cart -
Wild Hearts
$0.99Original price was: $0.99.$0.74Current price is: $0.74. Purchase & earn 7 points!Add to cart -
The Eye of Heaven
Rated 3.90 out of 5$9.99Original price was: $9.99.$7.49Current price is: $7.49. Purchase & earn 75 points!Add to cart





Reviews
There are no reviews yet.